Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3b safety study of Bexsero in healthy adults with blood collection for meningococcal vaccine development
2014-002972-95Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2014
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of meningococcal group B vaccine in meningococcal disease and bacterial meningitis, sponsored by Novartis. Started Sep 2014; status: completed.
02
Drugs
meningococcal group B vaccine
03
Conditions
meningococcal diseasebacterial meningitis
Beyond the preview
Go deeper on 2014-002972-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002972-95.